burger-menu close-panel
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Or Choose Category
Stem Cells & Therapies
On Women's Health
Chemical Abortion
Peer Reviewed
Fetal Development
Press Release
End of Life
Fetal Tissue, Stem Cells & Bioethics
Abortion
Maternal & Public Health
Research
Life & the Law
General
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Filter Results By

Filter Applied. Clear All
Results By Year
Research Type
By State
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

Home / About / Our Leadership/ Christina A. Cirucci, M.D.
Scholar

Christina A. Cirucci, M.D.

Associate Scholar

Christina A. Cirucci, M.D. is a board-certified OB/GYN and has worked for twenty years in private practice outside of Pittsburgh, PA. She received her Bachelor of Science in Mechanical Engineering from Virginia Tech in Blacksburg, VA in 1983, and then worked for seven years in the engineering field before pursuing a medical career. Dr. Cirucci earned her M.D. from Thomas Jefferson University in Philadelphia, PA in 1994, and completed her residency in Obstetrics and Gynecology at the Medical College of Virginia in Richmond, VA, in 1998. She also earned a Biblical Ministry Certificate from Columbia International University in Columbia, SC, in 2007. She is a diplomate of the American Board of Obstetrics and Gynecology and a Life Fellow of the American College of Obstetricians and Gynecologists. She is a member of the Christian Medical and Dental Associations, the Pennsylvania Medical Society, the Allegheny County Medical Society, and the North American Menopause Society, where she has received certification as a National Certified Menopause Practitioner. She is also a long-time member of the American Association of Pro-Life Obstetricians and Gynecologists, where she currently serves on the board of directors. She has published peer-reviewed articles in the medical literature on the complications of medication abortion. Dr. Cirucci has volunteered her medical skills in various third-world countries in Africa and Asia. She has traveled regularly to Bangladesh to provide medical care to women at Memorial Christian Hospital in Bangladesh.

Read Complete Bio

Research Authored

featured-image
General

A Cohort Study of Mental Health Services Utilization Following a First Pregnancy Abortion or Birth

A first pregnancy abortion, compared to a birth, is associated with significantly higher subsequent mental health services utilization following the first pregnancy outcome. The risk attributable to abortion is notably higher for inpatient than outpatient mental health services.

James Studnicki, Sc.D., MPH, MBA Tessa Longbons John W. Fisher, Ph.D., J.D., M.S., M.A. David C. Reardon, Ph.D. Ingrid Skop, M.D., FACOG Christina A. Cirucci, M.D. Donna Harrison, M.D.
July 10, 2023
ClosePlease loginn
featured-image
Peer Reviewed

A Post Hoc Exploratory Analysis: Induced Abortion Complications Mistaken for Miscarriage in the Emergency Room are a Risk Factor for Hospitalization

Previous research indicates that an increasing number of women who go to an emergency room for complications following an induced abortion are treated for a miscarriage, meaning their abortion is miscoded or concealed.

James Studnicki, Sc.D., MPH, MBA Tessa Longbons Ingrid Skop, M.D., FACOG Donna Harrison, M.D. Christina A. Cirucci, M.D. David C. Reardon, Ph.D. John W. Fisher, Ph.D., J.D., M.S., M.A.
May 20, 2022
ClosePlease loginn
American Reports Series

Overlooked Dangers of Mifepristone, the FDA’s Reduced REMS, and Self-Managed Abortion Policies: Unwanted Abortions, Unnecessary Abortions, Unsafe Abortions

The failure of abortion providers to support and undertake prospective longitudinal studies of a nationally representative sample of women contributes to our belief that the ideological biases of abortion providers have led to a combination of disinterest, willful ignorance, or even a conspiracy to hide the widespread dangers of unwanted and contraindicated abortions.

David C. Reardon, Ph.D. Donna Harrison, M.D. Ingrid Skop, M.D., FACOG Christina A. Cirucci, M.D. James Studnicki, Sc.D., MPH, MBA
December 16, 2021
ClosePlease loginn
featured-image
Life & the Law

Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019

Objectives: Primary: Analyze the Adverse Events (AEs) reported to the Food and Drug Administration (FDA) after use of mifepristone as an abortifacient. Secondary: Analyze maternal intent after ongoing pregnancy and investigate hemorrhage after mifepristone alone.

Kathi Aultman, M.D. Christina A. Cirucci, M.D. Donna Harrison, M.D.
November 1, 2021
ClosePlease loginn